These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1957722)

  • 1. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
    Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
    Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
    Elfving P; Lundgren R
    Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on adenocarcinoma of the prostate].
    Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
    Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
    Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
    Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of total prostatectomy for prostatic cancer].
    Fujii A; Gohji K; Morisue K; Maruyama S; Kizaki T; Oka N
    Hinyokika Kiyo; 1994 Feb; 40(2):111-7. PubMed ID: 8128919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostatic adenocarcinoma: nodal involvement and prognosis of stage D1 patients].
    Arai Y; Oishi K; Okada K; Yoshida O; Kihara Y; Okuno H
    Hinyokika Kiyo; 1989 Jun; 35(6):981-6. PubMed ID: 2801398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of prostate cancer--statistical analysis in the last 10 years].
    Yamamoto N; Shimabukuro T; Matsuyama H; Yoshihiro S; Mitsui H; Sakatoku J
    Hinyokika Kiyo; 1991 Jul; 37(7):705-10. PubMed ID: 1927770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
    Utz DC
    Urology; 1984 Nov; 24(5 Suppl):4-11. PubMed ID: 6495469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.
    Jones GW; Mettlin C; Murphy GP; Guinan P; Herr HW; Hussey DH; Chmiel JS; Fremgen AM; Clive RE; Zuber-Ocwieja KE
    J Am Coll Surg; 1995 May; 180(5):545-54. PubMed ID: 7538405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
    Gaur S; Aish LS; Oo TH
    J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
    [No Abstract]   [Full Text] [Related]  

  • 14. [The combined treatment of patients with locally disseminated prostatic cancer].
    Matveev BP; Iiazaliev KT
    Urol Nefrol (Mosk); 1993; (4):21-5. PubMed ID: 8310560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncologic after-care of patients with prostate cancer].
    Friedrich A; Glass W
    Z Urol Nephrol; 1986 Apr; 79(5):269-75. PubMed ID: 2426869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers in clinically localized prostate cancer.
    Pettaway CA
    Tech Urol; 1998 Mar; 4(1):35-42. PubMed ID: 9568775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate.
    Oefelein MG; Smith ND; Grayhack JT; Schaeffer AJ; McVary KT
    J Urol; 1997 Oct; 158(4):1460-5. PubMed ID: 9302143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A histological evaluation of the therapeutic effects and the clinical findings in prostatic carcinomas].
    Koike H; Ishikura K; Fujioka T; Kubo T; Fujie T; Tamura G
    Gan No Rinsho; 1990 May; 36(6):715-8. PubMed ID: 2348559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of incidental prostatic carcinoma].
    Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
    Hinyokika Kiyo; 1991 Feb; 37(2):135-9. PubMed ID: 2048491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.